The effect of adding buspirone to SSRIs in the treatment of obsessive-compulsive disorder
Phase 3
Recruiting
- Conditions
- Obsessive Compulsive Disorder.Obsessive-compulsive disorder
- Registration Number
- IRCT20180303038927N1
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Yale Brown criteria scale for Obsessive Compulsive Disorder (OCD) > 21 score
Patients will be selected according to the demographic information as: age/gender/marital status/education/job/onset age of illness/previous treatment/
age should be 18-60
The other psychiatric disease should not be existed
opioid/stimulant/should not be existed
Liver and Kidney diseases should not be existed
Exclusion Criteria
Yale Brown Scale below 21 scale
Opioid use disorders
Stimulant use disorders
Liver Failure
Kidney Failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Obsession scale according to Yale Brown Questionnaire. Timepoint: Comparison of Yale Brown scale in Buspirone group 6 weeks after the treatment. Method of measurement: Yale Brown Scale.;Obsession scale according to Yale Brown Questionnaire. Timepoint: Comparison of Yale Brown scale in Buspirone group in the end of the treatment. Method of measurement: Yale Brown Scale.;Obsession scale according to Yale Brown Questionnaire. Timepoint: Comparison of Yale Brown scale in Buspirone group with Placebo Group six weeks after the treatment. Method of measurement: Yale Brown Scale.;Obsession scale according to Yale Brown Questionnaire. Timepoint: Comparison of Yale Brown scale in Buspirone group with Placebo Group in the end of the treatment. Method of measurement: Yale Brown Scale.
- Secondary Outcome Measures
Name Time Method